164 related articles for article (PubMed ID: 8844830)
1. Functional implications of the modeled structure of maspin.
Fitzpatrick PA; Wong DT; Barr PJ; Pemberton PA
Protein Eng; 1996 Jul; 9(7):585-9. PubMed ID: 8844830
[TBL] [Abstract][Full Text] [Related]
2. The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin.
Pemberton PA; Wong DT; Gibson HL; Kiefer MC; Fitzpatrick PA; Sager R; Barr PJ
J Biol Chem; 1995 Jun; 270(26):15832-7. PubMed ID: 7797587
[TBL] [Abstract][Full Text] [Related]
3. Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule.
Ngamkitidechakul C; Warejcka DJ; Burke JM; O'Brien WJ; Twining SS
J Biol Chem; 2003 Aug; 278(34):31796-806. PubMed ID: 12799381
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of human maspin, a serpin with antitumor properties: reactive center loop of maspin is exposed but constrained.
Al-Ayyoubi M; Gettins PG; Volz K
J Biol Chem; 2004 Dec; 279(53):55540-4. PubMed ID: 15501821
[TBL] [Abstract][Full Text] [Related]
5. The reactive site loop of the serpin SCCA1 is essential for cysteine proteinase inhibition.
Schick C; Brömme D; Bartuski AJ; Uemura Y; Schechter NM; Silverman GA
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13465-70. PubMed ID: 9811823
[TBL] [Abstract][Full Text] [Related]
6. Maspin inhibits cell migration in the absence of protease inhibitory activity.
Bass R; Fernández AM; Ellis V
J Biol Chem; 2002 Dec; 277(49):46845-8. PubMed ID: 12384513
[TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop.
Becerra SP; Sagasti A; Spinella P; Notario V
J Biol Chem; 1995 Oct; 270(43):25992-9. PubMed ID: 7592790
[TBL] [Abstract][Full Text] [Related]
8. Production, purification, and characterization of recombinant maspin proteins.
Sheng S; Pemberton PA; Sager R
J Biol Chem; 1994 Dec; 269(49):30988-93. PubMed ID: 7983035
[TBL] [Abstract][Full Text] [Related]
9. SERPINB12 is a novel member of the human ov-serpin family that is widely expressed and inhibits trypsin-like serine proteinases.
Askew YS; Pak SC; Luke CJ; Askew DJ; Cataltepe S; Mills DR; Kato H; Lehoczky J; Dewar K; Birren B; Silverman GA
J Biol Chem; 2001 Dec; 276(52):49320-30. PubMed ID: 11604408
[TBL] [Abstract][Full Text] [Related]
10. Miropin, a novel bacterial serpin from the periodontopathogen Tannerella forsythia, inhibits a broad range of proteases by using different peptide bonds within the reactive center loop.
Ksiazek M; Mizgalska D; Enghild JJ; Scavenius C; Thogersen IB; Potempa J
J Biol Chem; 2015 Jan; 290(1):658-70. PubMed ID: 25389290
[TBL] [Abstract][Full Text] [Related]
11. Selective conservation of the RSL-encoding, proteinase inhibitory-type, clade L serpins in Caenorhabditis species.
Luke CJ; Pak SC; Askew DJ; Askew YS; Smith JE; Silverman GA
Front Biosci; 2006 Jan; 11():581-94. PubMed ID: 16146754
[TBL] [Abstract][Full Text] [Related]
12. mMaspin: the mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility.
Zhang M; Sheng S; Maass N; Sager R
Mol Med; 1997 Jan; 3(1):49-59. PubMed ID: 9132279
[TBL] [Abstract][Full Text] [Related]
13. Selective removal of individual disulfide bonds within a potato type II serine proteinase inhibitor from Nicotiana alata reveals differential stabilization of the reactive-site loop.
Schirra HJ; Guarino RF; Anderson MA; Craik DJ
J Mol Biol; 2010 Jan; 395(3):609-26. PubMed ID: 19925809
[TBL] [Abstract][Full Text] [Related]
14. High resolution structure of cleaved Serpin 42 Da from Drosophila melanogaster.
Ellisdon AM; Zhang Q; Henstridge MA; Johnson TK; Warr CG; Law RH; Whisstock JC
BMC Struct Biol; 2014 Apr; 14():14. PubMed ID: 24758516
[TBL] [Abstract][Full Text] [Related]
15. The high resolution crystal structure of the human tumor suppressor maspin reveals a novel conformational switch in the G-helix.
Law RH; Irving JA; Buckle AM; Ruzyla K; Buzza M; Bashtannyk-Puhalovich TA; Beddoe TC; Nguyen K; Worrall DM; Bottomley SP; Bird PI; Rossjohn J; Whisstock JC
J Biol Chem; 2005 Jun; 280(23):22356-64. PubMed ID: 15760906
[TBL] [Abstract][Full Text] [Related]
16. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
McGowen R; Biliran H; Sager R; Sheng S
Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
[TBL] [Abstract][Full Text] [Related]
17. Secondary structure changes stabilize the reactive-centre cleaved form of SERPINs. A study by 1H nuclear magnetic resonance and Fourier transform infrared spectroscopy.
Perkins SJ; Smith KF; Nealis AS; Haris PI; Chapman D; Bauer CJ; Harrison RA
J Mol Biol; 1992 Dec; 228(4):1235-54. PubMed ID: 1335516
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for serpin inhibitor activity.
Wright HT; Scarsdale JN
Proteins; 1995 Jul; 22(3):210-25. PubMed ID: 7479695
[TBL] [Abstract][Full Text] [Related]
19. Insight into the mechanism of serpin-proteinase inhibition from 2D [1H-15N] NMR studies of the 69 kDa alpha 1-proteinase inhibitor Pittsburgh-trypsin covalent complex.
Peterson FC; Gettins PG
Biochemistry; 2001 May; 40(21):6284-92. PubMed ID: 11371190
[TBL] [Abstract][Full Text] [Related]
20. Homologous proteins with different folds: the three-dimensional structures of domains 1 and 6 of the multiple Kazal-type inhibitor LEKTI.
Lauber T; Schulz A; Schweimer K; Adermann K; Marx UC
J Mol Biol; 2003 Apr; 328(1):205-19. PubMed ID: 12684009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
